Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Guizhi Jia, Chunguang Liang, Wenhui Li & Hongliang Dai. (2022) MiR-410-3p facilitates Angiotensin II–induced cardiac hypertrophy by targeting Smad7. Bioengineered 13:1, pages 119-127.
Read now
Read now
Articles from other publishers (27)
Jun Wang, Run Guo, Xiaoli Ma, Ying Wang, Qianyu Zhang, Nan Zheng, Jun Zhang & Chenchen Li. (2022) Liraglutide inhibits AngII-induced cardiac fibroblast proliferation and ECM deposition through regulating miR-21/PTEN/PI3K pathway. Cell and Tissue Banking 24:1, pages 125-137.
Crossref
Crossref
Collin Vandemark, Jimmy Nguyen & Zhi-Qing Zhao. (2023) Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update. Molecules 28:3, pages 1369.
Crossref
Crossref
Miyuki Kobara, Toshihiro Amano, Hiroe Toba & Tetsuo Nakata. (2022) Nicorandil Suppresses Ischemia-Induced Norepinephrine Release and Ventricular Arrhythmias in Hypertrophic Hearts. Cardiovascular Drugs and Therapy 37:1, pages 53-62.
Crossref
Crossref
Liu Huixing, Fu Di & Peng Daoquan. (2023) Effect of Glucagon-like Peptide-1 Receptor Agonists on Prognosis of Heart Failure and Cardiac Function: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical Therapeutics 45:1, pages 17-30.
Crossref
Crossref
Sukhwinder K. Bhullar & Naranjan S. Dhalla. (2022) Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy. Cells 11:21, pages 3336.
Crossref
Crossref
Qinchao Wu, Daisong Li, Chao Huang, Guoliang Zhang, Zheng Wang, Jiane Liu, Haichu Yu, Bingxue Song, Ning Zhang, Bing Li & Xianming Chu. (2022) Glucose control independent mechanisms involved in the cardiovascular benefits of glucagon-like peptide-1 receptor agonists. Biomedicine & Pharmacotherapy 153, pages 113517.
Crossref
Crossref
Jinxia Yuan & Guoliang Yuan. (2022) miR-212 Promotes Cardiomyocyte Hypertrophy through Regulating Transcription Factor 7 Like 2. Mediators of Inflammation 2022, pages 1-10.
Crossref
Crossref
Qiuhong Mou, Zhongli Jia, Min Luo, Lingjuan Liu, Xupei Huang, Junjun Quan & Jie Tian. (2022) Epigallocatechin-3-gallate exerts cardioprotective effects related to energy metabolism in pressure overload-induced cardiac dysfunction. Archives of Biochemistry and Biophysics 723, pages 109217.
Crossref
Crossref
Jun Wang, Yongzheng Liu, Changhui Ma, Yue Zhang, Meng Yuan & Guangping Li. (2022) Ameliorative Impact of Liraglutide on Chronic Intermittent Hypoxia-Induced Atrial Remodeling. Journal of Immunology Research 2022, pages 1-13.
Crossref
Crossref
Abhipree Sharma, Miles De Blasio & Rebecca Ritchie. (2022) Current challenges in the treatment of cardiac fibrosis: Recent insights into the sex‐specific differences of glucose‐lowering therapies on the diabetic heart: IUPHAR Review 33. British Journal of Pharmacology.
Crossref
Crossref
Aysegul Durak, Erman Akkus, Asena Gokcay Canpolat, Erkan Tuncay, Demet Corapcioglu & Belma Turan. (2021)
Glucagon‐like peptide‐1 receptor agonist treatment of high carbohydrate intake‐induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca
2+
abnormalities and mitochondrial dysfunction
. Clinical and Experimental Pharmacology and Physiology 49:1, pages 46-59.
Crossref
Crossref
Mei-Li Lu, Jing Wang, Yang Sun, Cong Li, Tai-Ran Sun, Xu-Wei Hou & Hong-Xin Wang. (2021) Ginsenoside Rg1 attenuates mechanical stress-induced cardiac injury via calcium sensing receptor-related pathway. Journal of Ginseng Research 45:6, pages 683-694.
Crossref
Crossref
Soraya Puglisi, Alessandro Rossini, Roberta Poli, Francesca Dughera, Anna Pia, Massimo Terzolo & Giuseppe Reimondo. (2021) Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System. Frontiers in Endocrinology 12.
Crossref
Crossref
Kanika Verma, Malvika Pant, Sarvesh Paliwal, Jaya Dwivedi & Swapnil Sharma. (2021) An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update. Frontiers in Pharmacology 12.
Crossref
Crossref
Lale A. Ertuglu, Esteban Porrini, Mads Hornum, Atalay Demiray, Baris Afsar, Alberto Ortiz, Adrian Covic, Peter Rossing & Mehmet Kanbay. (2021) Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation. Transplant International 34:8, pages 1341-1359.
Crossref
Crossref
Jing Wang, Shaohua Fan, Qianfeng Xiong, Yu Niu, Xin Zhang, Junnan Qin, Yawei Shi & Lihui Zhang. (2021) Glucagon-like peptide-1 attenuates cardiac hypertrophy via the AngII/AT1R/ACE2 and AMPK/mTOR/p70S6K pathways. Acta Biochimica et Biophysica Sinica 53:9, pages 1189-1197.
Crossref
Crossref
Hisashi Kai, Mamiko Kai, Hiroshi Niiyama, Norihito Okina, Motoki Sasaki, Takanobu Maeda & Atsushi Katoh. (2021) Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies. Hypertension Research 44:8, pages 955-968.
Crossref
Crossref
Xiaowen Shi, Bingjiang Han, Bin Zhang, Zhenliang Chu, Xueping Zhang, Qin Lu & Jibo Han. (2021) Schisandra chinensis polysaccharides prevent cardiac hypertrophy by dissociating thioredoxin-interacting protein/thioredoxin-1 complex and inhibiting oxidative stress. Biomedicine & Pharmacotherapy 139, pages 111688.
Crossref
Crossref
Farah Hamad, Asim Ahmed Elnour, Abdelgadir Elamin, Sasha Mohamed, Isra Yousif, Judit Don, Semira Abdi, Abdulla Al Amoodi, Ahmed Ibrahim Fathelrahman, Kishore Gnana, Fahad Alanzi, Abubakar B Abubakar, Salma Mohammed Magboul, Sahar Asim Ahmed & Adel Sadeq. (2021) Systematic Review of Glucagon-Like Peptide One Receptor Agonist Liraglutide of Subjects with Heart Failure with Reduced Left Ventricular Ejection Fraction. Current Diabetes Reviews 17:3, pages 280-292.
Crossref
Crossref
Peng Chen, Fen Yang, Wenya Wang, Xiao Li, Dongling Liu, Yongxi Zhang, Guotian Yin, Fenghua Lv, Zhikun Guo, Jawahar L. Mehta & Xianwei Wang. (2020) Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice. Journal of Cardiovascular Pharmacology and Therapeutics 26:2, pages 179-188.
Crossref
Crossref
Xiao-Jie Bai, Jun-Tao Hao, Rong-Hua Zheng, Cai-Ping Yan, Jin Wang, Cai-Hong Yang, Wei-Fang Zhang & Zhi-Qing Zhao. (2020) Glucagon-Like Peptide-1 Analog Liraglutide Attenuates Pressure-Overload Induced Cardiac Hypertrophy and Apoptosis through Activating ATP Sensitive Potassium Channels. Cardiovascular Drugs and Therapy 35:1, pages 87-101.
Crossref
Crossref
Lingling Wang, Yinyan Tang, Huimin He & Weirong Wei. (2021) Liraglutide restores late cardioprotective effects of remote preconditioning in diabetic rats via activation of hydrogen sulfide and nuclear factor erythroid 2-related factor 2 signaling pathway. Acta Cirúrgica Brasileira 36:2.
Crossref
Crossref
Dan Yang, Han-Qing Liu, Fang-Yuan Liu, Nan Tang, Zhen Guo, Shu-Qing Ma, Peng An, Ming-Yu Wang, Hai-Ming Wu, Zheng Yang, Di Fan & Qi-Zhu Tang. (2020) Critical roles of macrophages in pressure overload-induced cardiac remodeling. Journal of Molecular Medicine 99:1, pages 33-46.
Crossref
Crossref
Yana Lerner, Wessal Hanout, Shulamit Fluss Ben-Uliel, Samar Gani, Michal Pellach Leshem & Nir Qvit. (2020) Natriuretic Peptides as the Basis of Peptide Drug Discovery for Cardiovascular Diseases. Current Topics in Medicinal Chemistry 20:32, pages 2904-2921.
Crossref
Crossref
Gaojun Wu, Zhengxian Wang, Peiren Shan, Shanjun Huang, Shuang Lin, Weijian Huang & Zhouqing Huang. (2020) Suppression of Netrin-1 attenuates angiotension II-induced cardiac remodeling through the PKC/MAPK signaling pathway. Biomedicine & Pharmacotherapy 130, pages 110495.
Crossref
Crossref
Rong-Hua Zheng, Wei-Wei Zhang, Ye-Nan Ji, Xiao-Jie Bai, Cai-Ping Yan, Jin Wang, Feng Bai & Zhi-Qing Zhao. (2020) Exogenous supplement of glucagon like peptide-1 protects the heart against aortic banding induced myocardial fibrosis and dysfunction through inhibiting mTOR/p70S6K signaling and promoting autophagy. European Journal of Pharmacology 883, pages 173318.
Crossref
Crossref
Antonio Ceriello, Eberhard Standl, Doina Catrinoiu, Baruch Itzhak, Nebojsa M. Lalic, Dario Rahelic, Oliver Schnell, Jan Škrha & Paul Valensi. (2020) Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era. Diabetes Care 43:7, pages 1427-1432.
Crossref
Crossref